E-viri
Recenzirano
-
Castrejón-Castrejón, Sergio; Martínez Cossiani, Marcel; Jáuregui-Abularach, Miguel; Basterra Sola, Nuria; Ibáñez Criado, José Luis; Osca Asensi, Joaquín; Roca Luque, Ivo; Moya Mitjans, Angel; Quesada Dorador, Aurelio; Hidalgo Olivares, Víctor Manuel; Pérez Castellano, Nicasio; Fernández Gómez, Juan Manuel; Macías-Ruiz, María Rosa; Bochard Villanueva, Bruno; Gonzalo Bada, Nerea; Fernández Prieto, Andrés; Guido López, Leonardo Elías; Martínez Maldonado, María Eugenia; Merino, Daniel; Escobar Cervantes, Carlos; Merino, José Luis
Journal of interventional cardiac electrophysiology, 11/2023, Letnik: 66, Številka: 8Journal Article
Background Electrical isolation of pulmonary veins (PV) with high-power short-duration (HPSD) radiofrequency application (RFa) may reduce the duration of atrial fibrillation (AF) ablation, without compromising the procedural efficacy and safety in comparison with the conventional approach. This hypothesis has been generated in several observational studies; the POWER FAST III will test it in a randomized multicenter clinical trial. Methods It is a multicenter randomized, open-label and non-inferiority clinical trial with two parallel groups. AF ablation using 70 W and 9–10 s RFa is compared with the conventional technique using 25–40 W RFa guided by numerical lesion indexes. The main efficacy objective is the incidence of atrial arrhythmia recurrences electrocardiographically documented during 1-year follow-up. The main safety objective is the incidence of endoscopically detected esophageal thermal lesions (EDEL). This trial includes a substudy of incidence of asymptomatic cerebral lesions detected by magnetic resonance imaging (MRI) after ablation . Results A randomized clinical trial compares for the first time high-power short-duration and conventional ablation in order to obtain data about the efficacy and safety of the high-power technique in an adequate methodological context. Conclusions The results of the POWER FAST III could support the use of the high-power short-duration ablation in clinical practice. Registration : ClinicalTrials.gov: NTC04153747. Graphical Abstract
Avtor
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|
Vir: Osebne bibliografije
in: SICRIS
To gradivo vam je dostopno v celotnem besedilu. Če kljub temu želite naročiti gradivo, kliknite gumb Nadaljuj.